ABBV-467

ABBV-467 is a potent and selective MCL-1 inhibitor with sub-nanomolar binding affinity. It induces apoptosis and cell death, demonstrating efficacy in inhibiting tumor growth in preclinical models of hematological cancers like multiple myeloma, supporting its use in oncology research.